Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Phase I Study of Oral ASP5878 at Single and Multiple Doses in Patients With Solid Tumors

NCT02038673 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT02038673
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02038673 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Phase I Study of Oral ASP5878 at Single and Multiple Doses in Patients With Solid Tumors
Lead sponsor
Astellas Pharma Inc
Phase
Phase 1
Overall status
Completed
Start date
November 5, 2013
Completion date
July 19, 2017
Enrollment
86 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumors